Physician

Samuel Kofi Osei Okoh, MD

According to 2025 Medicare claims, Samuel Okoh, MD (NPI: 1730381252) practices nephrology in the Florence, SC market, with the plurality of this provider's patient population coming from Florence, SC. This provider's primary affiliated billing organization is PEE DEE NEPHROLOGY LLP (NPI: 1598825929; TIN: 570912581) and primary practice location at 29506-2606. Okoh is affiliated with the McLeod Healthcare Network, LLC (ACO ID: A3677), participating under the MSSP model.

Okoh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 764 traditional Medicare patients, billed 3,758 HCPCS/CPT codes, and received $296,872 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 4,795 prescription claims across 788 beneficiaries totaling $1,931,918 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 1,123 claims. Open Payments data shows 11 records totaling $2,282. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $453,162 to $1,931,918. For DME billing, reported payments rose steadily, from $17,091 to $77,450.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,163	5,692	$433,467
2016	1,156	5,936	$529,173
2017	1,196	6,201	$615,022
2018	1,158	6,301	$592,852
2019	1,155	6,600	$602,061
2020	1,100	6,186	$612,320
2021	873	4,464	$506,968
2022	738	3,671	$371,680
2023	746	3,757	$338,028
2024	764	3,758	$296,872

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	568	4,282	$453,162
2016	624	6,456	$1,101,300
2017	647	7,886	$1,504,323
2018	594	5,030	$841,192
2019	669	4,720	$1,009,736
2020	666	4,611	$905,273
2021	615	3,910	$799,259
2022	579	3,742	$872,256
2023	730	4,732	$2,351,027
2024	788	4,795	$1,931,918

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	189	$12,451
2016	113	391	$12,642
2017	314	1,373	$33,596
2018	361	1,425	$34,271
2019	512	2,099	$43,555
2020	475	1,710	$60,835
2021	352	1,469	$42,117
2022	377	1,451	$41,983
2023	332	1,291	$52,829
2024	240	1,123	$49,856

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	196	214	$95
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	282	460	$59
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	286	1,006	$58
90935	Hemodialysis procedure with physician evaluation	110	491	$53
81002	Urinalysis, manual test	166	257	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	847	30,091	$558,418
Jynarque	Tolvaptan	22	616	$424,691
Velphoro	Sucroferric Oxyhydroxide	102	3,240	$200,482
Jardiance	Empagliflozin	260	9,850	$193,331
Auryxia	Ferric Citrate	77	2,790	$148,345

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	20	$17,358
K0001	Standard wheelchair	Y	83	452	$10,230
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	12	68	$5,997
E0260	Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress	Y	20	78	$4,368
E0143	Walker, folding, wheeled, adjustable or fixed height	N	47	47	$2,701

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	11	$2,282	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Samuel Kofi Osei Okoh, MD?

Tedicare shows public-source Medicare data for Samuel Kofi Osei Okoh, MD (NPI 1730381252), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Samuel Kofi Osei Okoh, MD have ACO affiliation data?

Samuel Kofi Osei Okoh, MD is shown with ACO affiliation data for McLeod Healthcare Network, LLC (MSSP, ACO ID A3677).

What billing organization is linked to Samuel Kofi Osei Okoh, MD?

Samuel Kofi Osei Okoh, MD is linked to PEE DEE NEPHROLOGY LLP (billing NPI 1598825929) in the available physician profile data.

Does Samuel Kofi Osei Okoh, MD have Open Payments data?

Samuel Kofi Osei Okoh, MD has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.